Global Myotonic Dystrophy Drug Market Data Survey Report 2025

1 Global Market Overview

1.1 Scope of Statistics

1.1.1 Scope of Products

1.1.2 Scope of Manufacturers

1.1.3 Scope of Application

1.1.5 Scope of Regions/Countries

1.2 Global Market Size

2 Regional Market

2.1 Regional Production

2.2 Regional Demand

2.3 Regional Trade

3 Key Manufacturers

3.1 BioMarin Pharmaceutical Inc. 

3.1.2 Company Information

3.1.2 Product Specifications

3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.2 F. Hoffmann-La Roche Ltd. 

3.2.1 Company Information

3.2.2 Product Specifications

3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.3 Genzyme Corporation 

3.3.1 Company Information

3.3.2 Product Specifications

3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.4 Isis Pharmaceuticals, Inc. 

3.4.1 Company Information

3.4.2 Product Specifications

3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.5 Marina Biotech, Inc. 

3.5.1 Company Information

3.5.2 Product Specifications

3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.6 Valentia Biopharma S.L

3.6.1 Company Information

3.6.2 Product Specifications

3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.7 Valentia Biopharma S.L

3.7.1 Company Information

3.7.2 Product Specifications

3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

4 Major Application

4.1 Hospital 

4.1.1 Overview

4.1.2 Hospital  Market Size and Forecast

4.2 Clinic 

4.2.1 Overview

4.2.2 Clinic  Market Size and Forecast

4.3 Home Use 

4.3.1 Overview

4.3.2 Home Use  Market Size and Forecast

4.4 Others

4.4.1 Overview

4.4.2 Others Market Size and Forecast

5 Market by Type

5.1 ISIS-DMPKRx 

5.1.1 Overview

5.1.2 ISIS-DMPKRx  Market Size and Forecast

5.2 PRO-135 

5.2.1 Overview

5.2.2 PRO-135  Market Size and Forecast

5.3 SRT-152 

5.3.1 Overview

5.3.2 SRT-152  Market Size and Forecast

5.4 VAL-0411 

5.4.1 Overview

5.4.2 VAL-0411  Market Size and Forecast

5.5 Others

5.5.1 Overview

5.5.2 Others Market Size and Forecast

5.6 Others

5.6.1 Overview

5.6.2 Others Market Size and Forecast

6 Conclusion

Tab Regional Production 2011-2017 (Volume)

Tab Regional Demand and CAGR 2011-2017 (Million USD)

Tab Regional Demand and CAGR 2011-2017 (Volume)

Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)

Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)

Tab Regional Export 2011-2017 (Million USD)

Tab Regional Export 2011-2017 (Volume)

Tab Regional Import 2011-2017 (Million USD)

Tab Regional Import 2011-2017 (Volume)

Tab Sales Revenue, Volume, Price, Cost and Margin of BioMarin Pharmaceutical Inc. 

Tab Sales Revenue, Volume, Price, Cost and Margin of F. Hoffmann-La Roche Ltd. 

Tab Sales Revenue, Volume, Price, Cost and Margin of Genzyme Corporation 

Tab Sales Revenue, Volume, Price, Cost and Margin of Isis Pharmaceuticals, Inc. 

Tab Sales Revenue, Volume, Price, Cost and Margin of Marina Biotech, Inc. 

Tab Sales Revenue, Volume, Price, Cost and Margin of Valentia Biopharma S.L

Tab Sales Revenue, Volume, Price, Cost and Margin of Valentia Biopharma S.L